Skip to main content
SpringerLink
Log in

Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT)

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kumar L (1994) Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 12:1710–1717

    PubMed  CAS  Google Scholar 

  2. Graef T, Kuendgen A, Fenk R, Zohren F, Haas R, Kobbe G (2007) Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine. Leuk Res 31:257–259

    Article  PubMed  CAS  Google Scholar 

  3. Jabbour E, Giralt S, Kantarjian H, Garcia-Manero G, Jagasia M, Kebriaei P et al (2009) Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia. Cancer 115(9):1899–1905

    Article  PubMed  CAS  Google Scholar 

  4. de Lima M, Giralt S, Thall PF, de Padua Silva L, Jones RB, Komanduri K et al (2010) Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study. Cancer 116(23):5420–5431

    Article  PubMed  Google Scholar 

  5. Czibere A, Bruns I, Kroger N, Platzbecker U, Lind J, Zohren F et al (2010) 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis. Bone Marrow Transplant 45(5):872–876

    Article  PubMed  CAS  Google Scholar 

  6. Platzbecker U, Wermke M, Radke J, Oelsclaegel U, Seltmann F, Kiani A et al (2012) Azacytidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial. Leukemia 36:381–389

    Article  Google Scholar 

  7. Kantarjian HM, Thomas XG, Dmoszynska A, Wierzbowska A, Mazur G, Mayer J et al (2012) Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. J Clin Oncol 30:2670–26778

    Article  PubMed  CAS  Google Scholar 

  8. Ravandi F, Kantarjian H, Cohen A, Davis M, O’Brien S, Anderlini P et al (2001) Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study. Bone Marrow Transplant 27:1221–1225

    Article  PubMed  CAS  Google Scholar 

  9. Thomas X, Chelghoum Y, Cannas G, Elhamri M, Labussière H, Tigaud I et al (2011) Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making? Clin Lymphoma Myeloma Leuk 4:342–9

    Article  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. University of Kansas Medical Center, 2330 Shawnee Mission Parkway, Westwood, KS, 66205, USA

    Siddhartha Ganguly, Manik Amin, Clint Divine, Omar S. Aljitawi, Sunil Abhyankar & Joseph P. McGuirk

Authors
  1. Siddhartha Ganguly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manik Amin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Clint Divine
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Omar S. Aljitawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sunil Abhyankar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joseph P. McGuirk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Siddhartha Ganguly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ganguly, S., Amin, M., Divine, C. et al. Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT). Ann Hematol 92, 549–550 (2013). https://doi.org/10.1007/s00277-012-1607-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1607-y

Keywords

Search

Navigation